NeuroD1 increases HCC cell death resistance. by Ping Huang (30439)

Subjects:

DataSheet_1_Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors.zip by Ivan J. Cohen (5783102)

“…Patients whose tumors are resistant to immunotherapy often lack high levels of pre-existing inflammation in the tumor microenvironment. …”

DataSheet_2_Increased tumor glycolysis is associated with decreased immune infiltration across human solid tumors.zip by Ivan J. Cohen (5783102)

“…Patients whose tumors are resistant to immunotherapy often lack high levels of pre-existing inflammation in the tumor microenvironment. …”

SRC-3 treatment decreased tumor growth in a Jeko-1 ibrutinib resistant mouse model. by Imani Bijou (18275174)

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

Discovery of a Potent and Oral Available Complex I OXPHOS Inhibitor That Abrogates Tumor Growth and Circumvents MEKi Resistance by Peng He (24579)

Subjects:

High expression of Rpl22L1 is correlated with poor survival in CRC. by Shuyun Rao (449181)

Subjects:

5-FU resistant CRC-PDX samples exhibit increased Rpl22L1 staining. by Shuyun Rao (449181)

Subjects:

Inotodiol decreases clone formation in HCC cells. by Yushuang Xing (20636685)

“…In addition, inotodiol showed to induce apoptosis, characterized by an increase in Bax expression, a decrease in Bcl-2, Bcl-XL and MCL1 expression, the initiation of cleaved PARP1 and cleaved caspase 3, and inhibition of the MAPK/ERK pathway. …”

<i>RPL22</i> is frequently deleted in CRC and its loss results in induction of its highly homologous paralog, Rpl22L1. by Shuyun Rao (449181)

Subjects:

<i>CHGA</i> mRNA expression decreases with <i>CYB561</i> knockdown. by Romie Angelo G. Azur (18547651)

Cabozantinib treatment decreases microvessel density and increases hypoxic stress in SCNPC PDX models. by Mark P. Labrecque (10011469)

Low ATF3 expression is associated with decreased survival and EZH2 and ATF3 signatures inversely correlate in human prostate cancers. by Amy E. Schade (15368259)

Subjects:

Distributions of singscore-based EMT scores for TCGA samples across 32 tumor types using signature genes described in Mak MP, et al. (Clin Cancer Res. 2016;22: 609–620). by Angela Abdollahi (15166230)

Subjects:

Development of a Highly Efficient NIR-II Phototherapeutic Agent for Fluorescence Imaging-Guided Synergistic PTT/PDT/Chemotherapy of Colorectal Cancer by Ji Liu (110659)

Subjects:

RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance by Shuyun Rao (449181)

Subjects: